OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting
Paolo Cameli, Laura Bergantini, Miriana d’Alessandro, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 8, pp. 606-612
Closed Access | Times Cited: 21
Paolo Cameli, Laura Bergantini, Miriana d’Alessandro, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 8, pp. 606-612
Closed Access | Times Cited: 21
Showing 21 citing articles:
Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis
David Charles, Jemma Shanley, Sasha‐Nicole Temple, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 5, pp. 616-627
Open Access | Times Cited: 81
David Charles, Jemma Shanley, Sasha‐Nicole Temple, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 5, pp. 616-627
Open Access | Times Cited: 81
Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 400-400
Open Access | Times Cited: 13
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 400-400
Open Access | Times Cited: 13
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
Moritz Z. Kayser, Nora Drick, Katrin Milger, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 863-871
Open Access | Times Cited: 32
Moritz Z. Kayser, Nora Drick, Katrin Milger, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 863-871
Open Access | Times Cited: 32
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, et al.
Journal of Asthma (2021) Vol. 59, Iss. 11, pp. 2201-2217
Open Access | Times Cited: 29
Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, et al.
Journal of Asthma (2021) Vol. 59, Iss. 11, pp. 2201-2217
Open Access | Times Cited: 29
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis
Donald R. DiBona, Giovanni Paoletti, Palma Carlucci, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
Donald R. DiBona, Giovanni Paoletti, Palma Carlucci, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy
Fred Fyles, Amy Nuttall, Hannah Joplin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2715-2723
Open Access | Times Cited: 10
Fred Fyles, Amy Nuttall, Hannah Joplin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2715-2723
Open Access | Times Cited: 10
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 1
Open Access | Times Cited: 16
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 1
Open Access | Times Cited: 16
Long-Term Efficacy and Safety Among Patients With Severe Eosinophilic Asthma Treated With Mepolizumab and Its Effect on Small Airways
Ronald G. Strauss, Hannah Leflein, Anna Kolesar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 12, pp. 3670-3679.e2
Closed Access | Times Cited: 6
Ronald G. Strauss, Hannah Leflein, Anna Kolesar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 12, pp. 3670-3679.e2
Closed Access | Times Cited: 6
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
Lorenza Vantaggiato, Marco Perruzza, Rosa Metella Refini, et al.
Lung (2020) Vol. 198, Iss. 5, pp. 761-765
Closed Access | Times Cited: 15
Lorenza Vantaggiato, Marco Perruzza, Rosa Metella Refini, et al.
Lung (2020) Vol. 198, Iss. 5, pp. 761-765
Closed Access | Times Cited: 15
Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7132-7132
Open Access | Times Cited: 14
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7132-7132
Open Access | Times Cited: 14
Colorimetry-Based Detection of Nitric Oxide from Exhaled Breath for Quantification of Oxidative Stress in Human Body
Muni Raj Maurya, Haseena Onthath, Hagar Morsy, et al.
Healthcare (2021) Vol. 9, Iss. 8, pp. 1055-1055
Open Access | Times Cited: 14
Muni Raj Maurya, Haseena Onthath, Hagar Morsy, et al.
Healthcare (2021) Vol. 9, Iss. 8, pp. 1055-1055
Open Access | Times Cited: 14
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 5, pp. 593-605
Open Access | Times Cited: 10
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 5, pp. 593-605
Open Access | Times Cited: 10
Association Between Olfactory Function and Asthma in Adults
Hyo-In Rhyou, Woo Yong Bae, Young‐Hee Nam
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 309-316
Open Access | Times Cited: 9
Hyo-In Rhyou, Woo Yong Bae, Young‐Hee Nam
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 309-316
Open Access | Times Cited: 9
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment
Lorenza Vantaggiato, Paolo Cameli, Laura Bergantini, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 761-761
Open Access | Times Cited: 6
Lorenza Vantaggiato, Paolo Cameli, Laura Bergantini, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 761-761
Open Access | Times Cited: 6
A Single Center Experience of Super-Responders Among Severe Asthma Patients Receiving Treatment with Mepolizumab
Emel Atayık, Gökhan Aytekіn
Turkish Thoracic Journal (2022) Vol. 23, Iss. 5, pp. 348-354
Open Access | Times Cited: 5
Emel Atayık, Gökhan Aytekіn
Turkish Thoracic Journal (2022) Vol. 23, Iss. 5, pp. 348-354
Open Access | Times Cited: 5
Mepolizumab Effectiveness and Allergic Status in Real Life
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, et al.
International Archives of Allergy and Immunology (2020) Vol. 182, Iss. 4, pp. 311-318
Closed Access | Times Cited: 6
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, et al.
International Archives of Allergy and Immunology (2020) Vol. 182, Iss. 4, pp. 311-318
Closed Access | Times Cited: 6
Differential redox proteomic profiles of serum from severe asthma patients after one month of benralizumab and mepolizumab treatment
Claudia Landi, Lorenza Vantaggiato, Enxhi Shaba, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 70, pp. 102060-102060
Closed Access | Times Cited: 5
Claudia Landi, Lorenza Vantaggiato, Enxhi Shaba, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 70, pp. 102060-102060
Closed Access | Times Cited: 5
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, et al.
Respiratory Medicine and Research (2020) Vol. 78, pp. 100791-100791
Closed Access | Times Cited: 3
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, et al.
Respiratory Medicine and Research (2020) Vol. 78, pp. 100791-100791
Closed Access | Times Cited: 3
Evaluation of real-life data in patients with severe eosinophilic asthma treated with mepolizumab
Hale Ateş, Kurtuluş Aksu, İlkay Koca Kalkan, et al.
Journal of Medicine and Palliative Care (2022) Vol. 3, Iss. 3, pp. 275-279
Open Access
Hale Ateş, Kurtuluş Aksu, İlkay Koca Kalkan, et al.
Journal of Medicine and Palliative Care (2022) Vol. 3, Iss. 3, pp. 275-279
Open Access
Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Research Square (Research Square) (2021)
Open Access
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Research Square (Research Square) (2021)
Open Access
